Correction:
KZA agile trial which commences sometime next year is Phase 2 not Phase 3. If and only if the Agile phase2 has been completed successfully then the sequential phase 3 is able to commence. The sequential phase3 is expected to be complete in approximately 2 to 3 years. Hopefully the phase 3 results in about three years will confirm life extension of only a few months. This looks to be less than the competitors drug which seems to have superior results.
As always this my opinion and not advice.
- Forums
- ASX - By Stock
- KZA
- San Antonio Breast Cancer Symposium 8 Dec
San Antonio Breast Cancer Symposium 8 Dec, page-23
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online